Analyst Targets Race to Catch a Stock That Keeps Moving
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
CB enters the week after its October 21 earnings in an unusual spot: the Street is raising targets, but the stock has already drifted back below $356, leaving analysts scrambling to close a gap of their own making.
The most striking development since the post-earnings note is the breadth and speed of target revisions. Seven firms raised price targets in the six days following the print. Citigroup (Buy) pushed its target to $405, the most constructive read on the tape. JP Morgan lifted to $374 while holding Neutral. TD Cowen raised to $379 this morning, also at Hold. Morgan Stanley moved to $360 from $350 at Equal-Weight. The pattern is consistent: analysts are acknowledging the result was better than feared, but none are upgrading their ratings. Every firm that raised a target kept the same neutral-to-cautious stance. That tells the story plainly. The numbers came in, the Street updated its arithmetic, but conviction has not followed. The mean price target now sits around $366, only $10 above the current price, a thin buffer for a $136 billion insurer trading at 12 times earnings.
The bull case rests on Chubb's underwriting discipline and diversification. The 81.8% to 82% underlying combined ratio across segments held firm, reserve development was favourable, and capital returns ran at $1.57 billion in the third quarter. The bear case is harder to dismiss than it was a quarter ago: North America Commercial net premiums written declined 2.7%, middle-market growth slowed from 8.9% to 0.8%, and pricing has moderated in large accounts and property. The factor profile is mixed. The days-to-cover rank and borrow availability rank both score in the 88th percentile, reflecting how little bearish pressure exists in the stock. The short score of 28.6 has barely moved all month. EPS surprise scores at the 60th percentile, solid but not exceptional. Valuation multiples have expanded modestly: price-to-book moved up about 0.16 points over the past 30 days to 1.64, and the price-to-earnings ratio is around 12.1, up roughly half a point on the month.
Options positioning has settled into a mildly defensive posture, consistent with what the post-earnings note described. The put/call ratio is at 0.81, roughly one standard deviation above the 20-day average of 0.77. That is a shift from the call-heavy extreme that prevailed before the print. It is not aggressive hedging, the ratio is well below the 52-week high of 0.86, but investors are carrying a little more downside protection than they did a fortnight ago. Short interest is unchanged as a story: at 0.77% of the free float and down around 5% over the past month, bears have no meaningful foothold. Borrowing costs remain near their lowest levels of the year at 0.46%, and availability is essentially unlimited. There is no short-side pressure here.
Berkshire Hathaway's 8% stake remains the dominant ownership fact. The position has been static since at least the mid-2025 13G/A filing, with no reported change. Standard caveat applies: 13D/G disclosures are event-driven around the 5% threshold, and holders can fall below without filing again. Institutional flows from the quarter ending September 30 show BlackRock added around 1.2 million shares and T. Rowe added roughly 96,000. No holder in the top 15 shows a material reduction. Insider activity has been net negative over the past 90 days, with around $6.2 million in net selling since July. The most recent open-market sale was a director offloading $1.9 million in August. These are moderately sized discretionary sales worth watching but not yet a pattern that changes the read.
The next earnings date is January 26, giving the Street 90 days to resolve the gap between cautious ratings and an increasingly crowded set of targets just above the current price. The question worth tracking is whether North America Commercial growth stabilises, since that is the single metric bears are leaning on most heavily, and whether the stock can hold its post-earnings level long enough for analyst targets to feel like anchors rather than ceilings.
Stocks in this article
See the live data behind this article on ORTEX.
Open CB on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 19:45
- Data as of
- 28 Oct 2026, 19:45
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.